Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases De novo lipogenesis but does not cause dyslipidemia in conscious normal rats

Metabolism: Clinical and Experimental

Volumn 48, Issue 3, 1999, Pages 330-337

  Koopmans, Sietse J ^b   Kushwaha, Rampratap S ^b   DeFronzo, Ralph A ^a  

^a Univ of Texas Health Science Center ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOGENESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0032968656     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90081-1     Document Type: Article

References (44)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: A complex metabolic web. Coron Artery Dis 3:11-25, 1992
4. Reaven GM: Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension. Parallels between human disease and rodent models. Diabetes Care 14:195-202, 1991
5. Kasiske BL, O'Donnell MP, Keane WF: The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19:110-115, 1992
6. Reaven GM, Twersky J, Chang H: Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18:630-635, 1991
7. Stolba P, Dobesova Z, Husek P, et al: The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51:733-740, 1992
8. Kazumi T, Hirano T, Odaka H, et al: VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM. Diabetes 45:806-811, 1996
9. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
10. Mitchell BD, Haffner SM, Hazuda HP, et al: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 136:12-22, 1992
11. Cummings MH, Watts GF, Umpleby AM, et al: Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44:1059-1065, 1995
12. Steiner G, Haynes FJ, Yoshino G, et al: Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol 246:E187-E192, 1984
13. Bourgeois CS, Wiggins D, Gibbons GF: Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes. Biochem J 314:103-108, 1996
14. Lewis GF, Uffelman KD, Szeto LW, et al: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166, 1995
15. O'Brien T, Young WF, Palumbo PJ, et al: Hypertension and dyslipidemia in patients with insulinoma. Mayo Clin Proc 68:141-146, 1993
16. Leonetti F, Lozzo P, Giaccari A, et al: Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma. J Endocrinol Invest 16:875-880, 1993
17. McGuinness OP, Friedman A, Cherrington AD: Intraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog. Metabolism 39:127-132, 1990
18. Rosetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
19. Smith D, Rossetti L, Ferrannini E, et al: In vivo glucose metabolism in the awake rat. Tracer and insulin clamp studies. Metabolism 36:1167-1174, 1987
20. Koopmans SJ, de Boer SF, Sips HCM, et al: Whole body and hepatic insulin action in normal, starved and diabetic rats. Am J Physiol 260:E825-E832, 1991
21. Koopmans SJ, Maassen JA, Radder JK, et al: In vivo insulin responsiveness for glucose uptake at eu- and hyperglycemic levels in normal and diabetic rats. Biochim Biophys Acta 1115:230-238, 1992
22. McGill HC, McMahan CA, Kushwaha RS, et al: Dietary effects on serum lipoproteins of dyslipoproteinemic baboons with high HDL. Arteriosclerosis 6:651-663, 1986
23. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. J Clin Invest 85:1785-1792, 1990
24. Koopmans SJ, Mandarino L, DeFronzo RA: Time course of insulin action on tissue-specific intracellular glucose metabolism in conscious normal rats. Am J Physiol 274:E642-E650, 1998
25. Ferrannini E, Del Prato S, DeFronzo RA: Glucose kinetics: Tracer methods, in Lamer J, Pohl S (eds): Methods in Diabetes Research, vol 2. New York, NY, Wiley, 1985, pp 62-84
26. Kang ES, Betts D, Fain JN, et al: Chronic exposure of rat fat cells to insulin enhances lipolysis and activation of partially purified hormone-sensitive lipase. Diabetes 42:1415-1424, 1993
27. Koopmans SJ, Sips HCM, Krans HMJ, et al: Pulsatile intravenous insulin replacement in streptozotocin-diabetic rats is more efficient than continuous delivery: Effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis. Diabetologia 39:391-400, 1996
28. Randle PJ, Garland PB, Hales CN, et al: The glucose-fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
29. Nurjhan N, Consoli A, Gerich J: Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 89:169-175, 1992
30. Lombardo YB, Chicco A, D'Alessandro ME, et al: Dietary fish oil normalizes dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim Biophys Acta 1299:175-182, 1996
31. Koopmans SJ, Sips HCM, Bosman J, et al: Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations. Endocrinology 125:3044-3050, 1989
32. Cusin I, Terrettaz J, Rohner-Jeanrenaud F, et al: Metabolic consequences of hyperinsulinemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochem J 267:99-103, 1990
33. Wardzala LJ, Hirshman M, Pofcher E, et al: Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. J Clin Invest 76:460-469, 1985
34. Rizza RA, Mandarino LJ, Genest J, et al: Production of insulin resistance by hyperinsulinemia in man. Diabetologia 28:70-75, 1985
35. Del Prato S, Leonetti F, Simonson DC, et al: Effect of sustained physiologic hyperinsulinemia and hyperglycemia on insulin secretion and insulin sensitivity in man. Diabetologia 37:1025-1035, 1994
36. Azain MJ, Fukuda N, Chao FF, et al: Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity. J Biol Chem 260:174-181, 1985
37. Byrne CD, Wareham NJ, Brown DC, et al: Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: Relative contributions of insulin secretion, insulin resistance and suppression of plasmanon-esterified fatty acids. Diabetologia 37:889-896, 1994
38. Groop L, Bonadonna RC, DelPrato S, et al: Effect of insulin on oxidative and non-oxidative pathways of glucose and FFA metabolism in NIDDM. J Clin Invest 84:205-213, 1989
39. Howard BV, Schneiderman N, Falkner B, et al: Insulin, health behaviors, and lipid metabolism. Metabolism 42:25-35, 1993 (suppl 1)
40. Scoppola A, Testa G, Frontoni S, et al: Effects of insulin on cholesterol synthesis in type II diabetes patients. Diabetes Care 18:1363-1369, 1995
41. Tavanger K, Murata Y, Pedersen ME, et al: Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest 90:1672-1678, 1992
42. Terrettaz J, Cusin I, Etienne J, et al: In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats. Int J Obes 18:9-15, 1994
43. Reaven GM, Chen IDI: Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Am J Med 85:106-112, 1988
44. Boivin A, Deshaies Y: Dietary rat models in which the development of hypertriglyceridemia and that of insulin resistance are dissociated. Metabolism 44:1540-1547, 1995